Science News
from research organizations

Accelerated radiation therapy reduces toxicity in patients with advanced head and neck cancers

Date:
February 25, 2010
Source:
American Society for Radiation Oncology
Summary:
Using an accelerated, shorter course of radiation therapy for patients with advanced head and neck cancer allows doctors to reduce the amount of chemotherapy, thus reducing toxicity, according to a new study.
Share:
       
FULL STORY

Using an accelerated, shorter course of radiation therapy for patients with advanced head and neck cancer allows doctors to reduce the amount of chemotherapy, thus reducing toxicity, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM.

Between July 2002 and May 2005, this multi-institutional randomized phase III trial analyzed 721 patients with stage III-IV carcinoma of the oral cavity, oropharynx, hypopharynx or larynx, with 360 receiving accelerated radiation and 361 receiving standard radiation with two and three cycles of cisplatin, respectively.

After a median follow up of 4.8 years, the overall survival of accelerated radiation patients versus standard radiation patients was 59 percent and 56 percent respectively. Disease-free survival rates were 45 percent and 44 percent respectively and local-regional failure and metastasis rates were also very similar at 31 and 28 percent and 18 and 22 percent, respectively.

"Accelerated fractionation concurrent with two doses of high dose cisplatinum has the potential to reduce toxicity related to the chemotherapy regimen by not exposing patients to a third cycle," said, Phuc Felix Nguyen-Tan, M.D., presenter of the study for the RTOG and assistant professor of radiation oncology at CHUM Notre-Dame in Montreal, Canada.

The abstract, "A Phase III Trial to Test Accelerated versus Standard Fractionation in Combination with Concurrent Cisplatin for Head and Neck Carcinomas (RTOG 0129): Report of Efficacy and Toxicity," will be presented in the plenary session on February 26, 2010.


Story Source:

The above post is reprinted from materials provided by American Society for Radiation Oncology. Note: Materials may be edited for content and length.


Cite This Page:

American Society for Radiation Oncology. "Accelerated radiation therapy reduces toxicity in patients with advanced head and neck cancers." ScienceDaily. ScienceDaily, 25 February 2010. <www.sciencedaily.com/releases/2010/02/100225140858.htm>.
American Society for Radiation Oncology. (2010, February 25). Accelerated radiation therapy reduces toxicity in patients with advanced head and neck cancers. ScienceDaily. Retrieved July 4, 2015 from www.sciencedaily.com/releases/2010/02/100225140858.htm
American Society for Radiation Oncology. "Accelerated radiation therapy reduces toxicity in patients with advanced head and neck cancers." ScienceDaily. www.sciencedaily.com/releases/2010/02/100225140858.htm (accessed July 4, 2015).

Share This Page: